1. Home
  2. RDN vs KRYS Comparison

RDN vs KRYS Comparison

Compare RDN & KRYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RDN
  • KRYS
  • Stock Information
  • Founded
  • RDN 1977
  • KRYS 2015
  • Country
  • RDN United States
  • KRYS United States
  • Employees
  • RDN N/A
  • KRYS N/A
  • Industry
  • RDN Property-Casualty Insurers
  • KRYS Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • RDN Finance
  • KRYS Health Care
  • Exchange
  • RDN Nasdaq
  • KRYS Nasdaq
  • Market Cap
  • RDN 5.3B
  • KRYS 5.1B
  • IPO Year
  • RDN 1992
  • KRYS 2017
  • Fundamental
  • Price
  • RDN $34.62
  • KRYS $170.74
  • Analyst Decision
  • RDN Buy
  • KRYS Strong Buy
  • Analyst Count
  • RDN 5
  • KRYS 8
  • Target Price
  • RDN $36.10
  • KRYS $199.43
  • AVG Volume (30 Days)
  • RDN 1.4M
  • KRYS 256.8K
  • Earning Date
  • RDN 11-06-2024
  • KRYS 11-04-2024
  • Dividend Yield
  • RDN 2.83%
  • KRYS N/A
  • EPS Growth
  • RDN N/A
  • KRYS N/A
  • EPS
  • RDN 3.86
  • KRYS 1.77
  • Revenue
  • RDN $1,303,066,000.00
  • KRYS $241,519,000.00
  • Revenue This Year
  • RDN N/A
  • KRYS $485.65
  • Revenue Next Year
  • RDN $2.99
  • KRYS $58.64
  • P/E Ratio
  • RDN $8.98
  • KRYS $96.29
  • Revenue Growth
  • RDN 6.23
  • KRYS 2722.80
  • 52 Week Low
  • RDN $24.92
  • KRYS $97.30
  • 52 Week High
  • RDN $37.86
  • KRYS $219.34
  • Technical
  • Relative Strength Index (RSI)
  • RDN 52.76
  • KRYS 41.38
  • Support Level
  • RDN $34.19
  • KRYS $182.26
  • Resistance Level
  • RDN $34.88
  • KRYS $207.84
  • Average True Range (ATR)
  • RDN 1.03
  • KRYS 8.77
  • MACD
  • RDN 0.13
  • KRYS -0.21
  • Stochastic Oscillator
  • RDN 76.67
  • KRYS 16.02

About RDN Radian Group Inc.

Radian Group Inc provides mortgage insurance and services to the real estate and mortgage finance industries. Radian's mortgage insurance provides coverage to lending institutions throughout the United States. Its services include analytics and consulting for buyers and sellers of, and investors in, mortgage- and real estate-related loans and securities and other asset-backed securities. Insurance premiums account for more than three fourths of the company's revenue. Services revenue and investment income are the other principal sources of revenue. It operates in two segments: Mortgage and homegenius. The Mortgage segment earns the majority of revenue.

About KRYS Krystal Biotech Inc.

Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.

Share on Social Networks: